According to this New York Times article, the genetic repair process CRISPR may make it possible for pig hearts to replace human hearts. If this technology works, it would be good news for those awaiting transplant.
Currently, there are limited organs available with strict protocols for eligibility. A new source of suitable donor organs would be a great advance for heart transplantation.
Lisa Salberg, Founder and CEO of the Hypertrophic Cardiomyopathy Association, underwent a successful heart transplant last week at New Jersey’s Newark Beth Israel Hospital. Her experience is featured in this article published today on NorthJersey.com (The Bergen Record).
Lisa’s future plans include continuing her many advocacy efforts on behalf of HCM patients, as well as running in a 5K race. We have a feeling that Lisa will be competing in Track & Field events at the Transplant Games of America before you know it!
EDITED TO ADD STORIES ABOUT LISA HOLDING HER OLD HEART IN HER HANDS ON VALENTINE’S DAY IN ORDER TO EDUCATE OTHERS ABOUT HCM.
Inside Edition (with video)
News 12 New Jersey (with video)
BBC Radio Interview
A recent article published in Heart looked at the safety and effectiveness of catheter ablation for the treatment of Atrial Fibrillation in patients with HCM by performing a systematic review of prior publications on the subject.
The researchers concluded that even though the success rate for HCM patients was approximately half that of patients who suffered from AFib but did not have HCM, catheter ablation is still an effective treatment for HCM patients; especially for those HCM patients who suffer from paroxysmal AFib and who have smaller atria.